Drug Deal Disclosure Act mandates public release of drug pricing agreements between federal agencies and manufacturers.

The Drug Deal Disclosure Act requires the Department of Health and Human Services to disclose all records, documents, and communications related to agreements with drug manufacturers, including most favored nation pricing deals. These disclosures must be made publicly available within 30 days of the act's enactment. The bill prohibits withholding information based on reputational harm or political sensitivity. The Secretary must submit a report to Congress detailing the agreements, including summaries of redactions and withholdings.

Drug Deal Disclosure Act mandates public release of drug pricing agreements between federal agencies and manufacturers.

The Drug Deal Disclosure Act requires the Department of Health and Human Services to disclose all records, documents, and communications related to agreements with drug manufacturers, including most favored nation pricing deals. These disclosures must be made publicly available within 30 days of the act's enactment. The bill prohibits withholding information based on reputational harm or political sensitivity. The Secretary must submit a report to Congress detailing the agreements, including summaries of redactions and withholdings.